cut estim gvoltaren gel shift rx over-the-counter
non-prescript drug switch approv
cipla high product concentr us top three
product account us sale view
consolid profit one three product gvoltaren gel
prescrib temporari relief arthriti pain
usfda announc switch gvoltaren gel
rx over-the-counter full switch mean gvoltaren gel
longer avail prescript drug market
innov grant approv
supplement nda file
switch product rx over-the-counter
view gvoltaren gel bring mn annualis sale
cipla current profit hit gvoltaren gel
cut us sale mn next key drug
albuterol inhal expect
cut ep
gvoltaren gel alreadi factor eros henc hit
less cut tp
posit cipla higher focu india expect us ramp-up
slower gvoltaren hit
factor hit
figur cipla sale voltaren gel iqvia
estimate pot chg tp
number share mn
chg prev ep
supplement alreadi approv drug applic often
submiss includ studi show product label
read understood follow consum without guidanc
healthcar provid case gvoltaren gel innov
submit supplement nda grant
approv full rx over-the-counter switch
cipla highest market share gvoltaren gel
impact cipla highest market share
gvoltaren gel follow amneal endo togeth
despit entri new gener cipla abl
sustain market share view gvoltaren gel bring
mn annualis product cipla good ebitda margin
assum market share loss cipla
hit switch over-the-counter thu lower
instead assum sale sustain mn
gvoltaren gel top product shift rx over-the-counter cipla
mention confer call top product us
us sale view consolid
one cipla top product two
gsensipar
budesonid usfda
announc rx over-the-counter switch three drug voltaren arthriti
pain pataday pataday usfda clearli
mention press releas three product
market us non-prescript drug longer
avail prescript drug
prompt drug switch rx over-the-counter typic
innov submit data fda show drug appropri
self-administr data submit new drug applic
statu non-u analyst us disclosur credit suiss seek busi compani cover research report result investor
awar firm may conflict interest could affect object report investor consid report singl factor make invest
charl martineau pm univers toronto compani mention price
anubhav aggarw certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
price rate histori cipla limit cipl bo
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst
coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun octob
canadian well european exclud turkey rate base stock total return rel analyst coverag univers
consist compani cover analyst within relev sector outperform repres attract neutral less
attract underperform least attract invest opportun latin america turkey asia exclud japan australia
stock rate base stock total return rel averag total return relev countri region benchmark india
bse sensex index prior octob canadian rate base stock absolut total return potenti
current share price rel attract stock total return potenti within analyst coverag univers australian
new zealand stock expect total return calcul includ roll dividend yield outperform rate assign
greater equal under-perform less equal neutral may assign
overlap rate rang allow analyst assign rate put context associ risk
prior may rang outperform under-perform rate overlap neutral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
circumst
rate nr credit suiss equiti research invest rate view stock secur relat
compani time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate
invest view equiti secur compani relat product
volatil indic stock defin volatil stock price move month least
past month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or
valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform
